Bladder involvement in placenta accreta spectrum disorders: 2D US combined with the 3D crystal Vue and MRI comparative analysis

Placental accreta spectrum (PAS) disorder with bladder involvement is found to be associated with severe maternal and neonatal morbidity.When planning surgery or other treatments, a diagnosis and assessment of the invasiveness of placenta accreta spectrum disorder with bladder involvement are crucia...

Full description

Saved in:
Bibliographic Details
Published inBMC pregnancy and childbirth Vol. 24; no. 1; pp. 788 - 14
Main Authors Shuai, Xiufang, Gao, Chuanfen, Zhang, Hanqi, Zhang, Tingting, Li, Hongwen, Yan, Yunfang, Yao, Wen, Liu, Yu, Zhang, Chaoxue
Format Journal Article
LanguageEnglish
Published England BioMed Central 26.11.2024
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Placental accreta spectrum (PAS) disorder with bladder involvement is found to be associated with severe maternal and neonatal morbidity.When planning surgery or other treatments, a diagnosis and assessment of the invasiveness of placenta accreta spectrum disorder with bladder involvement are crucial.The detection of the depth of villi invasion can be accomplished with both MRI and US.The advent of three-dimensional Crystal Vue provides details additional information for scanning abnorma issue. Our goal was to compare and assess the diagnostic accuracy of 2D US combined with the 3D Crystal Vue and MRI in case of placenta accreta spectrum (PAS) involving the bladder. 111 pregnancy patients between May 2019 and November 2023 at the First Affiliated Hospital of Anhui Medical University whether or not they had placenta previa were included in the study if they were diagnosed of having placenta increta (PI) or placenta percreta (PP).Both US and MRI were used to evaluate the pregnant women.Total 53 pregnant women were ultimately included in our analysis.53 patients were split into groups with and without bladder involvement. They underwent 2D US,3D Crystal Vue, and MRI.The visual features of every subject were noted. Next, we analyzed the fundamental information, associated medical history, pregnancy outcomes, and different US and MRI signals between the two groups. To determine the potential contributing factors of PAS complicated with bladder involvement, a univariate analysis was performed. A multivariable logistic regression analysis was performed to identify US and MRI findings predictive of bladder involvement in placenta accreta spectrum. Multiple logistic regression analysis found that the bridging vessels (OR, 31.76,95% CI, 1.64-614.31,p = 0.022) and the tramline sign "fully" obliterated on Crystal Vue feature (OR, 68.92;95%CI,6.76-702.35,p < 0.001) were independently associated with an increased likelihood of bladder involvement. These findings when combined allowed for the prediction of bladder involvement with an 88.2% sensitivity, a 94.4% specificity, and an AUC of 0.933 (95% CI,0.829-0.983, p = 0.001). The results of the MRI logistic regression analysis were as follows: the three independent risk factors for bladder involvement were: Placental bulge (OR,57.99,95%CI,3.89-835.80,p = 0.003),Bladder wall interruption (OR,11.93, 95%CI, 1.60-88.85, p = 0.016), and Bladder vessel sign (OR, 9.75,95%CI, 1.43-66.21, p = 0.020).The joint diagnosis showed a sensitivity of 94.1% and specificity of 83.3%.The area under the curve was 0.942(95%CI,0.841-0.988). Regarding projected bladder involvement, there were no statistically significant differences between MRI and 2D integrated 3D Crystal Vue imaging. Both 2D coupled 3D Crystal Vue imaging and MRI are highly effective for predicting bladder invasion.Ultrasound is preferred over MRI because it is more convenient and more affordable.Among them, the tramline sign "fully" obliterated on 3D Crystal Vue was a new and reliable US sign for detecting bladder involvement.
AbstractList BackgroundPlacental accreta spectrum (PAS) disorder with bladder involvement is found to be associated with severe maternal and neonatal morbidity.When planning surgery or other treatments, a diagnosis and assessment of the invasiveness of placenta accreta spectrum disorder with bladder involvement are crucial.The detection of the depth of villi invasion can be accomplished with both MRI and US.The advent of three-dimensional Crystal Vue provides details additional information for scanning abnorma issue.PurposeOur goal was to compare and assess the diagnostic accuracy of 2D US combined with the 3D Crystal Vue and MRI in case of placenta accreta spectrum (PAS) involving the bladder.Materials and methods111 pregnancy patients between May 2019 and November 2023 at the First Affiliated Hospital of Anhui Medical University whether or not they had placenta previa were included in the study if they were diagnosed of having placenta increta (PI) or placenta percreta (PP).Both US and MRI were used to evaluate the pregnant women.Total 53 pregnant women were ultimately included in our analysis.53 patients were split into groups with and without bladder involvement. They underwent 2D US,3D Crystal Vue, and MRI.The visual features of every subject were noted. Next, we analyzed the fundamental information, associated medical history, pregnancy outcomes, and different US and MRI signals between the two groups. To determine the potential contributing factors of PAS complicated with bladder involvement, a univariate analysis was performed. A multivariable logistic regression analysis was performed to identify US and MRI findings predictive of bladder involvement in placenta accreta spectrum.ResultsMultiple logistic regression analysis found that the bridging vessels (OR, 31.76,95% CI, 1.64-614.31,p = 0.022) and the tramline sign “fully” obliterated on Crystal Vue feature (OR, 68.92;95%CI,6.76-702.35,p < 0.001) were independently associated with an increased likelihood of bladder involvement. These findings when combined allowed for the prediction of bladder involvement with an 88.2% sensitivity, a 94.4% specificity, and an AUC of 0.933 (95% CI,0.829–0.983, p = 0.001). The results of the MRI logistic regression analysis were as follows: the three independent risk factors for bladder involvement were: Placental bulge (OR,57.99,95%CI,3.89–835.80,p = 0.003),Bladder wall interruption (OR,11.93, 95%CI, 1.60-88.85, p = 0.016), and Bladder vessel sign (OR, 9.75,95%CI, 1.43–66.21, p = 0.020).The joint diagnosis showed a sensitivity of 94.1% and specificity of 83.3%.The area under the curve was 0.942(95%CI,0.841–0.988). Regarding projected bladder involvement, there were no statistically significant differences between MRI and 2D integrated 3D Crystal Vue imaging.ConclusionBoth 2D coupled 3D Crystal Vue imaging and MRI are highly effective for predicting bladder invasion.Ultrasound is preferred over MRI because it is more convenient and more affordable.Among them, the tramline sign “fully” obliterated on 3D Crystal Vue was a new and reliable US sign for detecting bladder involvement.
Placental accreta spectrum (PAS) disorder with bladder involvement is found to be associated with severe maternal and neonatal morbidity.When planning surgery or other treatments, a diagnosis and assessment of the invasiveness of placenta accreta spectrum disorder with bladder involvement are crucial.The detection of the depth of villi invasion can be accomplished with both MRI and US.The advent of three-dimensional Crystal Vue provides details additional information for scanning abnorma issue.BACKGROUNDPlacental accreta spectrum (PAS) disorder with bladder involvement is found to be associated with severe maternal and neonatal morbidity.When planning surgery or other treatments, a diagnosis and assessment of the invasiveness of placenta accreta spectrum disorder with bladder involvement are crucial.The detection of the depth of villi invasion can be accomplished with both MRI and US.The advent of three-dimensional Crystal Vue provides details additional information for scanning abnorma issue.Our goal was to compare and assess the diagnostic accuracy of 2D US combined with the 3D Crystal Vue and MRI in case of placenta accreta spectrum (PAS) involving the bladder.PURPOSEOur goal was to compare and assess the diagnostic accuracy of 2D US combined with the 3D Crystal Vue and MRI in case of placenta accreta spectrum (PAS) involving the bladder.111 pregnancy patients between May 2019 and November 2023 at the First Affiliated Hospital of Anhui Medical University whether or not they had placenta previa were included in the study if they were diagnosed of having placenta increta (PI) or placenta percreta (PP).Both US and MRI were used to evaluate the pregnant women.Total 53 pregnant women were ultimately included in our analysis.53 patients were split into groups with and without bladder involvement. They underwent 2D US,3D Crystal Vue, and MRI.The visual features of every subject were noted. Next, we analyzed the fundamental information, associated medical history, pregnancy outcomes, and different US and MRI signals between the two groups. To determine the potential contributing factors of PAS complicated with bladder involvement, a univariate analysis was performed. A multivariable logistic regression analysis was performed to identify US and MRI findings predictive of bladder involvement in placenta accreta spectrum.MATERIALS AND METHODS111 pregnancy patients between May 2019 and November 2023 at the First Affiliated Hospital of Anhui Medical University whether or not they had placenta previa were included in the study if they were diagnosed of having placenta increta (PI) or placenta percreta (PP).Both US and MRI were used to evaluate the pregnant women.Total 53 pregnant women were ultimately included in our analysis.53 patients were split into groups with and without bladder involvement. They underwent 2D US,3D Crystal Vue, and MRI.The visual features of every subject were noted. Next, we analyzed the fundamental information, associated medical history, pregnancy outcomes, and different US and MRI signals between the two groups. To determine the potential contributing factors of PAS complicated with bladder involvement, a univariate analysis was performed. A multivariable logistic regression analysis was performed to identify US and MRI findings predictive of bladder involvement in placenta accreta spectrum.Multiple logistic regression analysis found that the bridging vessels (OR, 31.76,95% CI, 1.64-614.31,p = 0.022) and the tramline sign "fully" obliterated on Crystal Vue feature (OR, 68.92;95%CI,6.76-702.35,p < 0.001) were independently associated with an increased likelihood of bladder involvement. These findings when combined allowed for the prediction of bladder involvement with an 88.2% sensitivity, a 94.4% specificity, and an AUC of 0.933 (95% CI,0.829-0.983, p = 0.001). The results of the MRI logistic regression analysis were as follows: the three independent risk factors for bladder involvement were: Placental bulge (OR,57.99,95%CI,3.89-835.80,p = 0.003),Bladder wall interruption (OR,11.93, 95%CI, 1.60-88.85, p = 0.016), and Bladder vessel sign (OR, 9.75,95%CI, 1.43-66.21, p = 0.020).The joint diagnosis showed a sensitivity of 94.1% and specificity of 83.3%.The area under the curve was 0.942(95%CI,0.841-0.988). Regarding projected bladder involvement, there were no statistically significant differences between MRI and 2D integrated 3D Crystal Vue imaging.RESULTSMultiple logistic regression analysis found that the bridging vessels (OR, 31.76,95% CI, 1.64-614.31,p = 0.022) and the tramline sign "fully" obliterated on Crystal Vue feature (OR, 68.92;95%CI,6.76-702.35,p < 0.001) were independently associated with an increased likelihood of bladder involvement. These findings when combined allowed for the prediction of bladder involvement with an 88.2% sensitivity, a 94.4% specificity, and an AUC of 0.933 (95% CI,0.829-0.983, p = 0.001). The results of the MRI logistic regression analysis were as follows: the three independent risk factors for bladder involvement were: Placental bulge (OR,57.99,95%CI,3.89-835.80,p = 0.003),Bladder wall interruption (OR,11.93, 95%CI, 1.60-88.85, p = 0.016), and Bladder vessel sign (OR, 9.75,95%CI, 1.43-66.21, p = 0.020).The joint diagnosis showed a sensitivity of 94.1% and specificity of 83.3%.The area under the curve was 0.942(95%CI,0.841-0.988). Regarding projected bladder involvement, there were no statistically significant differences between MRI and 2D integrated 3D Crystal Vue imaging.Both 2D coupled 3D Crystal Vue imaging and MRI are highly effective for predicting bladder invasion.Ultrasound is preferred over MRI because it is more convenient and more affordable.Among them, the tramline sign "fully" obliterated on 3D Crystal Vue was a new and reliable US sign for detecting bladder involvement.CONCLUSIONBoth 2D coupled 3D Crystal Vue imaging and MRI are highly effective for predicting bladder invasion.Ultrasound is preferred over MRI because it is more convenient and more affordable.Among them, the tramline sign "fully" obliterated on 3D Crystal Vue was a new and reliable US sign for detecting bladder involvement.
Placental accreta spectrum (PAS) disorder with bladder involvement is found to be associated with severe maternal and neonatal morbidity.When planning surgery or other treatments, a diagnosis and assessment of the invasiveness of placenta accreta spectrum disorder with bladder involvement are crucial.The detection of the depth of villi invasion can be accomplished with both MRI and US.The advent of three-dimensional Crystal Vue provides details additional information for scanning abnorma issue. Our goal was to compare and assess the diagnostic accuracy of 2D US combined with the 3D Crystal Vue and MRI in case of placenta accreta spectrum (PAS) involving the bladder. 111 pregnancy patients between May 2019 and November 2023 at the First Affiliated Hospital of Anhui Medical University whether or not they had placenta previa were included in the study if they were diagnosed of having placenta increta (PI) or placenta percreta (PP).Both US and MRI were used to evaluate the pregnant women.Total 53 pregnant women were ultimately included in our analysis.53 patients were split into groups with and without bladder involvement. They underwent 2D US,3D Crystal Vue, and MRI.The visual features of every subject were noted. Next, we analyzed the fundamental information, associated medical history, pregnancy outcomes, and different US and MRI signals between the two groups. To determine the potential contributing factors of PAS complicated with bladder involvement, a univariate analysis was performed. A multivariable logistic regression analysis was performed to identify US and MRI findings predictive of bladder involvement in placenta accreta spectrum. Multiple logistic regression analysis found that the bridging vessels (OR, 31.76,95% CI, 1.64-614.31,p = 0.022) and the tramline sign "fully" obliterated on Crystal Vue feature (OR, 68.92;95%CI,6.76-702.35,p < 0.001) were independently associated with an increased likelihood of bladder involvement. These findings when combined allowed for the prediction of bladder involvement with an 88.2% sensitivity, a 94.4% specificity, and an AUC of 0.933 (95% CI,0.829-0.983, p = 0.001). The results of the MRI logistic regression analysis were as follows: the three independent risk factors for bladder involvement were: Placental bulge (OR,57.99,95%CI,3.89-835.80,p = 0.003),Bladder wall interruption (OR,11.93, 95%CI, 1.60-88.85, p = 0.016), and Bladder vessel sign (OR, 9.75,95%CI, 1.43-66.21, p = 0.020).The joint diagnosis showed a sensitivity of 94.1% and specificity of 83.3%.The area under the curve was 0.942(95%CI,0.841-0.988). Regarding projected bladder involvement, there were no statistically significant differences between MRI and 2D integrated 3D Crystal Vue imaging. Both 2D coupled 3D Crystal Vue imaging and MRI are highly effective for predicting bladder invasion.Ultrasound is preferred over MRI because it is more convenient and more affordable.Among them, the tramline sign "fully" obliterated on 3D Crystal Vue was a new and reliable US sign for detecting bladder involvement.
Abstract Background Placental accreta spectrum (PAS) disorder with bladder involvement is found to be associated with severe maternal and neonatal morbidity.When planning surgery or other treatments, a diagnosis and assessment of the invasiveness of placenta accreta spectrum disorder with bladder involvement are crucial.The detection of the depth of villi invasion can be accomplished with both MRI and US.The advent of three-dimensional Crystal Vue provides details additional information for scanning abnorma issue. Purpose Our goal was to compare and assess the diagnostic accuracy of 2D US combined with the 3D Crystal Vue and MRI in case of placenta accreta spectrum (PAS) involving the bladder. Materials and methods 111 pregnancy patients between May 2019 and November 2023 at the First Affiliated Hospital of Anhui Medical University whether or not they had placenta previa were included in the study if they were diagnosed of having placenta increta (PI) or placenta percreta (PP).Both US and MRI were used to evaluate the pregnant women.Total 53 pregnant women were ultimately included in our analysis.53 patients were split into groups with and without bladder involvement. They underwent 2D US,3D Crystal Vue, and MRI.The visual features of every subject were noted. Next, we analyzed the fundamental information, associated medical history, pregnancy outcomes, and different US and MRI signals between the two groups. To determine the potential contributing factors of PAS complicated with bladder involvement, a univariate analysis was performed. A multivariable logistic regression analysis was performed to identify US and MRI findings predictive of bladder involvement in placenta accreta spectrum. Results Multiple logistic regression analysis found that the bridging vessels (OR, 31.76,95% CI, 1.64-614.31,p = 0.022) and the tramline sign “fully” obliterated on Crystal Vue feature (OR, 68.92;95%CI,6.76-702.35,p < 0.001) were independently associated with an increased likelihood of bladder involvement. These findings when combined allowed for the prediction of bladder involvement with an 88.2% sensitivity, a 94.4% specificity, and an AUC of 0.933 (95% CI,0.829–0.983, p = 0.001). The results of the MRI logistic regression analysis were as follows: the three independent risk factors for bladder involvement were: Placental bulge (OR,57.99,95%CI,3.89–835.80,p = 0.003),Bladder wall interruption (OR,11.93, 95%CI, 1.60-88.85, p = 0.016), and Bladder vessel sign (OR, 9.75,95%CI, 1.43–66.21, p = 0.020).The joint diagnosis showed a sensitivity of 94.1% and specificity of 83.3%.The area under the curve was 0.942(95%CI,0.841–0.988). Regarding projected bladder involvement, there were no statistically significant differences between MRI and 2D integrated 3D Crystal Vue imaging. Conclusion Both 2D coupled 3D Crystal Vue imaging and MRI are highly effective for predicting bladder invasion.Ultrasound is preferred over MRI because it is more convenient and more affordable.Among them, the tramline sign “fully” obliterated on 3D Crystal Vue was a new and reliable US sign for detecting bladder involvement.
ArticleNumber 788
Author Liu, Yu
Zhang, Chaoxue
Shuai, Xiufang
Li, Hongwen
Zhang, Tingting
Yan, Yunfang
Gao, Chuanfen
Zhang, Hanqi
Yao, Wen
Author_xml – sequence: 1
  givenname: Xiufang
  surname: Shuai
  fullname: Shuai, Xiufang
– sequence: 2
  givenname: Chuanfen
  surname: Gao
  fullname: Gao, Chuanfen
– sequence: 3
  givenname: Hanqi
  surname: Zhang
  fullname: Zhang, Hanqi
– sequence: 4
  givenname: Tingting
  surname: Zhang
  fullname: Zhang, Tingting
– sequence: 5
  givenname: Hongwen
  surname: Li
  fullname: Li, Hongwen
– sequence: 6
  givenname: Yunfang
  surname: Yan
  fullname: Yan, Yunfang
– sequence: 7
  givenname: Wen
  surname: Yao
  fullname: Yao, Wen
– sequence: 8
  givenname: Yu
  surname: Liu
  fullname: Liu, Yu
– sequence: 9
  givenname: Chaoxue
  orcidid: 0000-0002-3037-8819
  surname: Zhang
  fullname: Zhang, Chaoxue
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39593009$$D View this record in MEDLINE/PubMed
BookMark eNpdkk1v1DAQhiNURD_gD3BAlrhwCdixvY65IGgLrFSEBJSrNbEnXa-SeGsni_bUv47TLVXLwZrR-PE7o_F7XBwMYcCieMnoW8bqxbvEqroWJa3yWWitSv2kOGJCsbLimh88yA-L45TWlDJVS_qsOORaak6pPipuPnXgHEbih23ottjjMOacbDqwOQUC1kbMMW3QjnHqifMpxPwivSfVGbn8SWzoGz-gI3_8uCLjCgk_Izbu0ggd-T0hgcGRbz-WM7iBCKPfzjXodsmn58XTFrqEL-7iSXH5-fzX6dfy4vuX5enHi9JKJseycbqqbd0gY6i4rSVHqYAx5xop65Y6KppWtVXjAIWWSsmqbUGhVhKEcIyfFMu9rguwNpvoe4g7E8Cb20KIVwbi6G2HRqCijkvuWNsKXlPIPbRCRykglXqRtT7stTZT06Ob9xSheyT6-GbwK3MVtoYxqSnnKiu8uVOI4XrCNJreJ4tdBwOGKRnOOBdsoenc7PV_6DpMMW9vpkRVaSG0yNSrhyPdz_LvozNQ7QEbQ0oR23uEUTO7yezdZLKbzK2bjOZ_AV3dvYQ
Cites_doi 10.1016/j.jogc.2018.12.004
10.1007/s00404-019-05420-5
10.1002/ijgo.12409
10.1002/ijgo.12407
10.2214/AJR.21.25581
10.1002/uog.23734
10.1002/ijgo.15493
10.11152/mu-2578
10.1080/14767058.2020.1846699
10.1002/uog.17346
10.1002/uog.14952
10.1016/j.ajog.2014.11.018
10.1007/s13669-019-00267-8
10.1002/ijgo.12408
10.1155/2022/8128689
10.1053/plac.2001.0764
10.1111/bju.13332
10.1007/s00261-019-02008-0
10.4103/UA.UA_84_18
10.1016/j.jacr.2020.01.031
10.1016/j.ejogrb.2023.05.036
10.2214/AJR.17.19303
10.1016/j.ejrad.2023.110695
10.37015/AUDT.2021.200067
10.1111/jog.15208
10.1002/ijgo.12370
10.1016/S0022-5347(05)67153-4
10.1002/uog.6284
10.1002/uog.13426
10.1371/journal.pone.0052893
10.1016/j.ajog.2019.01.233
10.18502/jri.v23i4.10814
10.1016/j.ajog.2014.08.019
10.1016/j.ajogmf.2024.101321
10.1055/a-1309-1665
10.1111/aogs.14143
10.1016/j.diii.2019.02.004
10.1186/s12884-021-03818-1
10.1016/j.ajog.2017.02.050
10.1016/s0002-9378(96)70117-5
10.1111/ajo.13703
10.3109/14767058.2011.576720
10.1080/14767058.2023.2183764
10.1002/ijgo.12410
10.1016/s0002-9378(16)34741-x
10.1007/s00330-008-0862-8
10.1186/s12884-020-03041-4
10.1097/01.AOG.0000219750.79480.84
10.1111/j.1600-0412.2012.01527.x
10.5005/jp-journals-10009_1519
10.1515/jpm-2012-0219
10.1016/j.ajog.2021.03.018
10.1016/j.ajog.2017.05.067
10.1177/0284185116638567
10.1002/ijgo.12761
10.1002/uog.13327
10.1016/j.bpobgyn.2020.07.006
ContentType Journal Article
Copyright 2024. The Author(s).
2024. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2024 2024
Copyright_xml – notice: 2024. The Author(s).
– notice: 2024. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2024 2024
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7RV
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9-
K9.
KB0
M0R
M0S
M1P
NAPCQ
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12884-024-06997-9
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
Consumer Health Database (Alumni Edition)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Consumer Health Database
Health & Medical Collection (Alumni Edition)
Medical Database
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Family Health (Alumni Edition)
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database
MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-2393
EndPage 14
ExternalDocumentID oai_doaj_org_article_4e70d353d1ff4380adb597ed00ae0596
PMC11590337
39593009
10_1186_s12884_024_06997_9
Genre Journal Article
Comparative Study
GeographicLocations United States--US
GeographicLocations_xml – name: United States--US
GrantInformation_xml – fundername: the Research fund Project of Anhui institude of Translational Medicine
  grantid: 2021zhyx-C35
GroupedDBID ---
0R~
23N
2WC
53G
5GY
5VS
6J9
6PF
7RV
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACUHS
ADBBV
ADRAZ
ADUKV
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
AZQEC
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BKNYI
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
IAO
ICW
IHR
INH
INR
ITC
K9-
KQ8
M0R
M1P
M48
M~E
N8Y
NAPCQ
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
~8M
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7XB
8FK
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c515t-bd928c8be11e73c853e57a11ddb558f0d04bf7f2bdae4957752ffa7e975a44d13
IEDL.DBID M48
ISSN 1471-2393
IngestDate Wed Aug 27 01:27:03 EDT 2025
Thu Aug 21 18:32:31 EDT 2025
Thu Jul 10 21:24:54 EDT 2025
Fri Jul 25 23:17:34 EDT 2025
Thu Apr 03 07:27:29 EDT 2025
Tue Jul 01 03:59:09 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Magnetic resonance imaging
Crystal Vue
Placenta accreta spectrum
Language English
License 2024. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c515t-bd928c8be11e73c853e57a11ddb558f0d04bf7f2bdae4957752ffa7e975a44d13
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-3037-8819
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12884-024-06997-9
PMID 39593009
PQID 3142294494
PQPubID 44759
PageCount 14
ParticipantIDs doaj_primary_oai_doaj_org_article_4e70d353d1ff4380adb597ed00ae0596
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11590337
proquest_miscellaneous_3133416906
proquest_journals_3142294494
pubmed_primary_39593009
crossref_primary_10_1186_s12884_024_06997_9
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-11-26
PublicationDateYYYYMMDD 2024-11-26
PublicationDate_xml – month: 11
  year: 2024
  text: 2024-11-26
  day: 26
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC pregnancy and childbirth
PublicationTitleAlternate BMC Pregnancy Childbirth
PublicationYear 2024
Publisher BioMed Central
BMC
Publisher_xml – name: BioMed Central
– name: BMC
References E Jauniaux (6997_CR37) 2017; 217
RM Silver (6997_CR11) 2006; 107
SL Collins (6997_CR31) 2016; 47
I Kumar (6997_CR24) 2017; 58
SM Shijing (6997_CR18) 2022; 6
JC Shih (6997_CR19) 2009; 33
L Sentilhes (6997_CR43) 2018; 140
H Ali (6997_CR36) 2021; 72
TK Tam (6997_CR41) 2012; 25
G Masselli (6997_CR57) 2008; 18
E Jauniaux (6997_CR3) 2019; 146
Y Peng (6997_CR45) 2020; 20
RK Luke (6997_CR2) 1966; 95
A Dall’Asta (6997_CR27) 2022; 43
E Jauniaux (6997_CR50) 2018; 218
F Chantraine (6997_CR51) 2019; 8
H You (6997_CR7) 2024; 166
N Tillu (6997_CR13) 2019; 11
J Balayla (6997_CR12) 2013; 41
F D’Antonio (6997_CR23) 2014; 44
KE Fitzpatrick (6997_CR4) 2012; 7
E Jauniaux (6997_CR8) 2019; 221
A Bhatia (6997_CR39) 2022; 59
G Cali (6997_CR17) 2017; 11
CN Liu (6997_CR35) 2021; 21
C Bourgioti (6997_CR22) 2018; 211
AA Shamshirsaz (6997_CR16) 2015; 212
A Dall’Asta (6997_CR20) 2017; 49
S Chen (6997_CR32) 2020; 22
JC Shih (6997_CR49) 2021; 225
TK Adu-Bredu (6997_CR52) 2023; 63
E Jauniaux (6997_CR1) 2018; 140
P Jha (6997_CR55) 2019; 44
M Tadayon (6997_CR6) 2022; 23
JM O’Brien (6997_CR42) 1996; 175
IE Timor-Tritsch (6997_CR38) 2014; 44
C Giuseppe (6997_CR44) 2023; 287
X Chen (6997_CR25) 2020; 301
L Poder (6997_CR33) 2020; 17
BL Norris (6997_CR47) 2016; 117
RM Silver (6997_CR46) 2015; 212
W Jariyawattanarat (6997_CR14) 2023; 160
S Xin (6997_CR28) 2022; 2022
E Jauniaux (6997_CR30) 2018; 140
O Morel (6997_CR34) 2019; 100
JM Palacios-Jaraquemada (6997_CR58) 2013; 92
F Abbas (6997_CR15) 2000; 164
JM Palacios-Jaraquemada (6997_CR29) 2023; 36
Y Gielchinsky (6997_CR5) 2002; 23
E Barzilay (6997_CR26) 2022; 35
H Maynard (6997_CR53) 2018; 140
S Thiravit (6997_CR54) 2021; 217
L Allen (6997_CR40) 2018; 140
R Konijeti (6997_CR48) 2009; 11
H Ishibashi (6997_CR10) 2021; 100
A Al-Khan (6997_CR56) 2022; 48
SR Hobson (6997_CR9) 2019; 41
TK Adu-Bredu (6997_CR21) 2024; 6
References_xml – volume: 41
  start-page: 1035
  year: 2019
  ident: 6997_CR9
  publication-title: J Obstet Gynaecol Can
  doi: 10.1016/j.jogc.2018.12.004
– volume: 301
  start-page: 851
  year: 2020
  ident: 6997_CR25
  publication-title: Arch Gynecol Obstet
  doi: 10.1007/s00404-019-05420-5
– volume: 140
  start-page: 281
  year: 2018
  ident: 6997_CR40
  publication-title: Int J Gynecol Obstet
  doi: 10.1002/ijgo.12409
– volume: 140
  start-page: 265
  year: 2018
  ident: 6997_CR1
  publication-title: Int J Gynecol Obstet
  doi: 10.1002/ijgo.12407
– volume: 217
  start-page: 1377
  year: 2021
  ident: 6997_CR54
  publication-title: Am J Roentgenol
  doi: 10.2214/AJR.21.25581
– volume: 59
  start-page: 40
  year: 2022
  ident: 6997_CR39
  publication-title: Ultrasound Obstet Gynecol
  doi: 10.1002/uog.23734
– volume: 166
  start-page: 1092
  year: 2024
  ident: 6997_CR7
  publication-title: Int J Gynecol Obstet
  doi: 10.1002/ijgo.15493
– volume: 22
  start-page: 438
  year: 2020
  ident: 6997_CR32
  publication-title: Med Ultrason
  doi: 10.11152/mu-2578
– volume: 35
  start-page: 4056
  year: 2022
  ident: 6997_CR26
  publication-title: J Matern -Fetal Neonatal Med
  doi: 10.1080/14767058.2020.1846699
– volume: 49
  start-page: 549
  year: 2017
  ident: 6997_CR20
  publication-title: Ultrasound Obstet Gynecol
  doi: 10.1002/uog.17346
– volume: 47
  start-page: 271
  year: 2016
  ident: 6997_CR31
  publication-title: Ultrasound Obstet Gynecol
  doi: 10.1002/uog.14952
– volume: 212
  start-page: 561
  year: 2015
  ident: 6997_CR46
  publication-title: Am J Obstet Gynecol
  doi: 10.1016/j.ajog.2014.11.018
– volume: 8
  start-page: 86
  year: 2019
  ident: 6997_CR51
  publication-title: Curr Obstet Gynecol Rep
  doi: 10.1007/s13669-019-00267-8
– volume: 140
  start-page: 274
  year: 2018
  ident: 6997_CR30
  publication-title: Int J Gynecol Obstet
  doi: 10.1002/ijgo.12408
– volume: 2022
  start-page: 1
  year: 2022
  ident: 6997_CR28
  publication-title: J Healthc Eng
  doi: 10.1155/2022/8128689
– volume: 23
  start-page: 210
  year: 2002
  ident: 6997_CR5
  publication-title: Placenta
  doi: 10.1053/plac.2001.0764
– volume: 117
  start-page: 961
  year: 2016
  ident: 6997_CR47
  publication-title: Bju Int
  doi: 10.1111/bju.13332
– volume: 44
  start-page: 2572
  year: 2019
  ident: 6997_CR55
  publication-title: Abdom Radiol
  doi: 10.1007/s00261-019-02008-0
– volume: 11
  start-page: 324
  year: 2019
  ident: 6997_CR13
  publication-title: Urol Annals
  doi: 10.4103/UA.UA_84_18
– volume: 17
  start-page: S207
  year: 2020
  ident: 6997_CR33
  publication-title: J Am Coll Radiol
  doi: 10.1016/j.jacr.2020.01.031
– volume: 287
  start-page: 93
  year: 2023
  ident: 6997_CR44
  publication-title: Eur J Obstet Gynecol Reprod Biol
  doi: 10.1016/j.ejogrb.2023.05.036
– volume: 211
  start-page: 701
  year: 2018
  ident: 6997_CR22
  publication-title: Am J Roentgenol
  doi: 10.2214/AJR.17.19303
– volume: 160
  start-page: 110695DOI
  year: 2023
  ident: 6997_CR14
  publication-title: Eur J Radiol
  doi: 10.1016/j.ejrad.2023.110695
– volume: 6
  start-page: 1
  year: 2022
  ident: 6997_CR18
  publication-title: Adv Ultrasound Diagnosis Therapy
  doi: 10.37015/AUDT.2021.200067
– volume: 48
  start-page: 1149
  year: 2022
  ident: 6997_CR56
  publication-title: J Obstet Gynaecol Res
  doi: 10.1111/jog.15208
– volume: 140
  start-page: 332
  year: 2018
  ident: 6997_CR53
  publication-title: Int J Gynecol Obstet
  doi: 10.1002/ijgo.12370
– volume: 164
  start-page: 1270
  year: 2000
  ident: 6997_CR15
  publication-title: J Urol
  doi: 10.1016/S0022-5347(05)67153-4
– volume: 33
  start-page: 193
  year: 2009
  ident: 6997_CR19
  publication-title: Ultrasound Obstet Gynecol
  doi: 10.1002/uog.6284
– volume: 44
  start-page: 346
  year: 2014
  ident: 6997_CR38
  publication-title: Ultrasound Obstet Gynecol
  doi: 10.1002/uog.13426
– volume: 7
  start-page: e52893DOI
  year: 2012
  ident: 6997_CR4
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0052893
– volume: 221
  start-page: 208
  year: 2019
  ident: 6997_CR8
  publication-title: Am J Obstet Gynecol
  doi: 10.1016/j.ajog.2019.01.233
– volume: 23
  start-page: 279
  year: 2022
  ident: 6997_CR6
  publication-title: J Reprod Infertil
  doi: 10.18502/jri.v23i4.10814
– volume: 212
  start-page: 211
  year: 2015
  ident: 6997_CR16
  publication-title: Am J Obstet Gynecol
  doi: 10.1016/j.ajog.2014.08.019
– volume: 6
  start-page: 101321DOI
  year: 2024
  ident: 6997_CR21
  publication-title: Amer J Obstet Gynecol Mfm
  doi: 10.1016/j.ajogmf.2024.101321
– volume: 43
  start-page: e118
  year: 2022
  ident: 6997_CR27
  publication-title: Ultraschall Med
  doi: 10.1055/a-1309-1665
– volume: 100
  start-page: 1019
  year: 2021
  ident: 6997_CR10
  publication-title: Acta Obstet Gynecol Scand
  doi: 10.1111/aogs.14143
– volume: 100
  start-page: 319
  year: 2019
  ident: 6997_CR34
  publication-title: Diagn Interv Imaging
  doi: 10.1016/j.diii.2019.02.004
– volume: 11
  start-page: 173
  year: 2009
  ident: 6997_CR48
  publication-title: Rev Urol
– volume: 21
  start-page: 332DOI
  year: 2021
  ident: 6997_CR35
  publication-title: Bmc Pregnancy Childbirth
  doi: 10.1186/s12884-021-03818-1
– volume: 217
  start-page: 27
  year: 2017
  ident: 6997_CR37
  publication-title: Am J Obstet Gynecol
  doi: 10.1016/j.ajog.2017.02.050
– volume: 175
  start-page: 1632
  year: 1996
  ident: 6997_CR42
  publication-title: Am J Obstet Gynecol
  doi: 10.1016/s0002-9378(96)70117-5
– volume: 63
  start-page: 725
  year: 2023
  ident: 6997_CR52
  publication-title: Aust N Z J Obstet Gynaecol
  doi: 10.1111/ajo.13703
– volume: 25
  start-page: 329
  year: 2012
  ident: 6997_CR41
  publication-title: J Matern -Fetal Neonatal Med
  doi: 10.3109/14767058.2011.576720
– volume: 36
  start-page: 2183764DOI
  year: 2023
  ident: 6997_CR29
  publication-title: J Matern -Fetal Neonatal Med
  doi: 10.1080/14767058.2023.2183764
– volume: 140
  start-page: 291
  year: 2018
  ident: 6997_CR43
  publication-title: Int J Gynecol Obstet
  doi: 10.1002/ijgo.12410
– volume: 95
  start-page: 660
  year: 1966
  ident: 6997_CR2
  publication-title: Am J Obstet Gynecol
  doi: 10.1016/s0002-9378(16)34741-x
– volume: 18
  start-page: 1292
  year: 2008
  ident: 6997_CR57
  publication-title: Eur Radiol
  doi: 10.1007/s00330-008-0862-8
– volume: 20
  start-page: 349DOI
  year: 2020
  ident: 6997_CR45
  publication-title: Bmc Pregnancy Childbirth
  doi: 10.1186/s12884-020-03041-4
– volume: 107
  start-page: 1226
  year: 2006
  ident: 6997_CR11
  publication-title: Obstet Gynecol
  doi: 10.1097/01.AOG.0000219750.79480.84
– volume: 92
  start-page: 392
  year: 2013
  ident: 6997_CR58
  publication-title: Acta Obstet Gynecol Scand
  doi: 10.1111/j.1600-0412.2012.01527.x
– volume: 11
  start-page: 177
  year: 2017
  ident: 6997_CR17
  publication-title: Donald School J Ultrasound Obstet Gynecol
  doi: 10.5005/jp-journals-10009_1519
– volume: 41
  start-page: 141
  year: 2013
  ident: 6997_CR12
  publication-title: J Perinat Med
  doi: 10.1515/jpm-2012-0219
– volume: 225
  start-page: 291
  year: 2021
  ident: 6997_CR49
  publication-title: Am J Obstet Gynecol
  doi: 10.1016/j.ajog.2021.03.018
– volume: 218
  start-page: 75
  year: 2018
  ident: 6997_CR50
  publication-title: Am J Obstet Gynecol
  doi: 10.1016/j.ajog.2017.05.067
– volume: 58
  start-page: 121
  year: 2017
  ident: 6997_CR24
  publication-title: Acta Radiol
  doi: 10.1177/0284185116638567
– volume: 146
  start-page: 20
  year: 2019
  ident: 6997_CR3
  publication-title: Int J Gynecol Obstet
  doi: 10.1002/ijgo.12761
– volume: 44
  start-page: 8
  year: 2014
  ident: 6997_CR23
  publication-title: Ultrasound Obstet Gynecol
  doi: 10.1002/uog.13327
– volume: 72
  start-page: 4
  year: 2021
  ident: 6997_CR36
  publication-title: Best Pract Res Clin Obstet Gynaecol
  doi: 10.1016/j.bpobgyn.2020.07.006
SSID ssj0017850
Score 2.386986
Snippet Placental accreta spectrum (PAS) disorder with bladder involvement is found to be associated with severe maternal and neonatal morbidity.When planning surgery...
BackgroundPlacental accreta spectrum (PAS) disorder with bladder involvement is found to be associated with severe maternal and neonatal morbidity.When...
Abstract Background Placental accreta spectrum (PAS) disorder with bladder involvement is found to be associated with severe maternal and neonatal...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 788
SubjectTerms Adult
Bladder
Comparative analysis
Crystal Vue
Female
Gynecology
Humans
Imaging, Three-Dimensional
Interfaces
Magnetic resonance imaging
Magnetic Resonance Imaging - methods
Obstetrics
Performance evaluation
Placenta Accreta - diagnostic imaging
Placenta accreta spectrum
Placenta Previa - diagnostic imaging
Pregnancy
Sensitivity and Specificity
Ultrasonography, Prenatal
Urinary Bladder - diagnostic imaging
Urinary Bladder - pathology
Urinary Bladder Diseases - diagnostic imaging
Urinary Bladder Diseases - etiology
Uterus
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbxUhECemB-PF-O1qNZh4M6SwsHx4s9ammjwP6jO9EVggNmm35n0ceuq_7gy779lnTLx42wAHlhlmfsMMPwh57XRJQiTNWhk5U4FLFgHWsgLQwpkYbBB433n2WZ_M1afT7vTGU19YEzbSA48Ld6Cy4Ul2MolSkB09pAgYOCfOQ8anY9D6gs_bBFNT_sDYjm-uyFh9sAQrbBUDf8S4Rv5Rt-OGKlv_3yDmn5WSN1zP8T1yd8KM9N041_vkVh4ekNuzKSv-kFwfnqP9WNCzAYxNJQBfwTet9VbDKtDQ91hWSOu1ysX6gqaJc3P5lrZHdP6Vgt5BiJwTxXNZCqCQyiPaL64AO57T7-tMw5Do7MtH2v9mC4e2kdDkEZkff_j2_oRNDyuwHuDLisXkWtvbmIXIRvbgsXNnAogM1razhSeuYjGljSlkCKCM6dpSgsnOdEGpJORjsjdcDvkpoUUDgAPDEAPEXb2xARNzukdSfRB0KQ15s1ln_3Pkz_A17rDaj1LxIBVfpeJdQw5RFNuRyH1dG0Aj_KQR_l8a0ZD9jSD9tCGXXuJZl1PKqYa82nbDVsL8SBjy5RrHSPDpyNzckCej3LczkUjgDHi0IXZHI3amutsznP2odN2AuR2X0jz7Hz_3nNxpUY2FYK3eJ3ugNPkFwKJVfFl3wC8vwQsT
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSIgL4k1KQUbihqw6sRPbXBClVAVpOQCL9mb5CZVKtuzjwKl_nRknu2UR4hYlPlj5xjPf2ONvCHlhuhzrOnasEZ4z6bhgHmgty0AtjPJOuxrvO08-dqdT-WHWzsYNt-VYVrnxicVRx3nAPfJDgZsVRkojX1_8ZNg1Ck9XxxYa18kNlC7Dki412yZc2Hieby7K6O5wCb5YSwZRifEOVUjNTjAqmv3_Ipp_10v-EYBO7pDbI3Okbwao75Jrqb9Hbk7Gs_H75PLoHL3Igp714HKKDPgKnmmpuupXjroQsLiQlsuVi_UPGkflzeUr2hzT6WcKfwIS5RQp7s5SoIZUHNOw-AUM8px-XSfq-kgnn97TcKUZDu8GWZMHZHry7svbUza2V2ABSMyK-WgaHbRPdZ2UCBC3U6scABd92-rMI5c-q9z46BKkUUq1Tc5OJaNaJ2WsxUOy18_79JjQ3AGNA_fgHWRfQWmHx3NdQGl9gDvnirzc_Gd7Maho2JJ96M4OqFhAxRZUrKnIEUKxHYkK2OXFfPHNjgvKyqR4FK2Idc6omu9g1kalyLlL2FKoIgcbIO24LJf2yogq8nz7GRYUnpK4Ps3XOEZAZEf95oo8GnDfzkSgjDOw0oroHYvYmerul_7sexHtBuZtuBBq___zekJuNWigdc2a7oDsgTmkp0B7Vv5Zse3fwScChg
  priority: 102
  providerName: ProQuest
Title Bladder involvement in placenta accreta spectrum disorders: 2D US combined with the 3D crystal Vue and MRI comparative analysis
URI https://www.ncbi.nlm.nih.gov/pubmed/39593009
https://www.proquest.com/docview/3142294494
https://www.proquest.com/docview/3133416906
https://pubmed.ncbi.nlm.nih.gov/PMC11590337
https://doaj.org/article/4e70d353d1ff4380adb597ed00ae0596
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bi9QwFD7sBcQX8W51HSL4JtW2SZtEEHHcXVZhFhkdGXwJSZPowtjRzgy4T_51TzLtrCPz4EspTWlDzu07uXwH4KmsvM1zW6UFNVnKdEZTg7A29QgtJDda6Dycdx6dV2cT9n5aTvegL3fUDeBiZ2oX6klN2tnzXz8vX6PBv4oGL6oXC_SxgqUYbdKsCuyich8OMTLxYKgjdrWqwEWs2JqjQ04D9Vd_iGbnN7YCVeTz3wVC_91L-VdwOr0JNzpUSd6s1eAW7LnmNlwbdevmd-D3cBY8TEsuGnRHkSJ8ifck7shqlproug4bD0k8eNmuvhPbsXIuXpLimEw-EtRMTKKdJWHmliBsJPSY1O0lossZ-bxyRDeWjMbvSH3FJ47P1pQnd2FyevLp7VnalV5IawQ4y9RYWYhaGJfnjtMaY7oruUahWlOWwmc2Y8ZzXxirHaZYnJeF95o7yUvNmM3pPTho5o17AMRXCPHQdRiNmVnNhQ5Ld1UdaPdRFbxP4Fk_zurHmmFDxcxEVGotFYVSUVEqSiYwDKLYvBnYseODeftVdcammOOZpSW1ufeBUV9jryV3Nsu0C-WGEjjqBal6jVM0zIZJxiRL4MmmGY0trKDoxs1X4R2KUT9wOydwfy33TU9ooHhGxJqA2NKIra5utzQX3yKhN6JymVHKH_7Hjx_B9SJoaY4qXB3BAeqEe4y4aGkGsM-nfACHw5PzD-NBnF0YRAPA63j45Q-gKA4p
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrQRcEG8CBYwEJ2Q1iZ04QUKIZVvt0u4KlRb1ZpzYhkolW_Yh1BP_iN_ITB5bFiFuvUWJFY0845lvPPY3AM_z1NsosimPRRFyaULBC4S13CO0yFVhMhPRfefxJB0eyffHyfEG_OruwtCxys4n1o7aTkvaI98WtFmRS5nLN2ffOXWNoupq10KjMYs9d_4DU7b569EA9fsijnd3Dt8NedtVgJcYuxe8sHmclVnhosgpUWK4cokyKK8tkiTzoQ1l4ZWPC2scZg9KJbH3RrlcJUZKGwn87xXYlAJTmR5s9ncmHw5WdQuVJWF3NSdLt-fo_TPJMQ7yMCXe03wt_NVdAv4Fbf8-oflHyNu9CTdarMreNsZ1CzZcdRuujttq_B342T8lvzVjJxU6uZp4fIHPrD7nVS0MM2VJxxlZfZ1ztvzGbMv1OX_F4gE7-shw7jE1d5bRfjBDMMrEgJWzc8Ssp-zT0jFTWTY-GLHygqUc3zVEKnfh6FKm_h70qmnlHgDzKQJHdEiFwXyvVJmhgmBaEpk_Gpj3Abzs5lmfNbwdus53slQ3WtGoFV1rRecB9EkVq5HEuV2_mM6-6HYJa-lUaEUibOQ98fQblDpXzoahcdTEKICtTpG6dQRzfWG2ATxbfcYlTHUZU7npksYIxBLEGB3A_UbvK0kEEUcjDg4gW7OINVHXv1QnX2uacMT6eSiEevh_uZ7CteHheF_vjyZ7j-B6TMYaRTxOt6CHpuEeI-haFE9aS2fw-bIX129UeUHF
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Bladder+involvement+in+placenta+accreta+spectrum+disorders%3A+2D+US+combined+with+the+3D+crystal+Vue+and+MRI+comparative+analysis&rft.jtitle=BMC+pregnancy+and+childbirth&rft.au=Shuai%2C+Xiufang&rft.au=Gao%2C+Chuanfen&rft.au=Zhang%2C+Hanqi&rft.au=Zhang%2C+Tingting&rft.date=2024-11-26&rft.issn=1471-2393&rft.eissn=1471-2393&rft.volume=24&rft.issue=1&rft.spage=788&rft_id=info:doi/10.1186%2Fs12884-024-06997-9&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2393&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2393&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2393&client=summon